State Street Corp Boosts Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

State Street Corp boosted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 1.4% in the third quarter, HoldingsChannel.com reports. The firm owned 3,540,791 shares of the company’s stock after buying an additional 50,597 shares during the quarter. State Street Corp’s holdings in Pediatrix Medical Group were worth $41,038,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MD. nVerses Capital LLC purchased a new stake in shares of Pediatrix Medical Group in the second quarter valued at approximately $31,000. Innealta Capital LLC purchased a new stake in Pediatrix Medical Group during the second quarter worth approximately $33,000. Quest Partners LLC boosted its stake in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of Pediatrix Medical Group by 47.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after buying an additional 1,524 shares during the last quarter. Finally, Quarry LP raised its position in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Insider Activity

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the transaction, the director now owns 138,683 shares of the company’s stock, valued at $2,128,784.05. This represents a 16.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the sale, the executive vice president now directly owns 135,810 shares in the company, valued at $2,172,960. The trade was a 5.63 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on MD. Truist Financial raised their target price on Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research report on Monday, November 4th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a report on Monday, November 4th. Mizuho increased their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Finally, StockNews.com cut Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Thursday. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.42.

Pediatrix Medical Group Stock Down 1.1 %

Pediatrix Medical Group stock opened at $14.09 on Friday. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of -4.60, a P/E/G ratio of 2.00 and a beta of 1.57. The firm has a fifty day moving average price of $14.15 and a two-hundred day moving average price of $10.92. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $16.41. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The firm had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The firm’s revenue for the quarter was up .9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.29 EPS. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.